Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Alcon Inc.
  6. Company
    ALC   CH0432492467

ALCON INC.

(ALC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Alcon Inc.
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.

Number of employees : 23 655 people.
Sales per Business
20192020Delta
Surgical4 148.0555.6%3 482.2654.3% -16.05%
Vision Care3 168.1842.5%2 865.5944.7% -9.55%
CHF in Million
Sales per region
20192020Delta
United States3 036.0140.7%2 792.3843.5% -8.02%
Other3 197.9942.9%2 534.2639.5% -20.75%
Japan651.928.7%610.109.5% -6.42%
China374.665%359.495.6% -4.05%
Switzerland55.650.7%51.620.8% -7.24%
CHF in Million
Managers
Name Title Age Since
David Endicott Chief Executive Officer & Director 55 -
Timothy Stonesifer Chief Financial Officer & Senior Vice President 53 2019
Franck Leveiller Head-Global Research & Development - 2015
Sue-Jean Lin Chief Information Officer & Senior Vice President - -
Lynn Dorsey Bleil Independent Director 56 2019
Arthur Cummings, Dr. Independent Director 57 -
Thomas Heinrich Glanzmann Independent Director 62 -
Scott Maw Independent Director 52 -
Karen J. May Independent Director 61 -
Ines Pöschel Independent Director 52 -
Members of the board
Name Title Age Since
F. Ball Chairman 65 2018
David Endicott Chief Executive Officer & Director 55 -
Lynn Dorsey Bleil Independent Director 56 2019
Arthur Cummings, Dr. Independent Director 57 -
Thomas Heinrich Glanzmann Independent Director 62 -
D. Grossman Vice Chairman 59 2019
Scott Maw Independent Director 52 -
Karen J. May Independent Director 61 -
Ines Pöschel Independent Director 52 -
Dieter Spälti, Dr. Independent Director 60 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 499,700,000 488,916,698 97.8% 10,500,000 2.1% 97.8%
Shareholders
NameEquities%
Aristotle Capital Management LLC 14,648,771 2.93%
Credit Suisse Securities (USA) LLC (Broker) 13,583,612 2.72%
T. Rowe Price Associates, Inc. (Investment Management) 11,505,624 2.30%
Norges Bank Investment Management 11,202,279 2.24%
ClearBridge Investments LLC 10,794,895 2.16%
The Vanguard Group, Inc. 10,672,767 2.14%
AKO Capital LLP 6,265,169 1.25%
Credit Suisse Asset Management (Schweiz) AG 6,147,953 1.23%
Brown Brothers Harriman & Co. (Investment Management) 6,022,831 1.21%
WCM Investment Management LLC 6,016,079 1.20%
Markets and indexes
- Main Standard
- SMI / STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ALC.S
- Datastream Code :  
Company contact information
Alcon Inc.
Rue 6
CH-1701 Freiburg, Freiburg

Phone : +41 589 112 110
Fax :
web site : https://investor.alcon.com
Sector Glasses, Spectacles & Contact Lenses